Showing results (1091-1100 of 2,642) with videos related to

Sort By:
Pageof 265
Hematology (Amsterdam, Netherlands)|December 28, 2020
The association between pre-transfusion hemoglobin levels and thalassemia complicationsWasuwit Wanchaitanawong, Adisak Tantiworawit, Pokpong Piriyakhuntorn, et al.
Hematology (Amsterdam, Netherlands)|January 6, 2021
Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaMengnan Lyu, Erlie Jiang, Yi He, et al.
Hematology (Amsterdam, Netherlands)|January 6, 2021
Analysis of gamma-glutamyltransferase in acute promyelocytic leukemia patients undergoing arsenic trioxide treatmentMeijuan Sui, Hong Wei, Qian Zhang, et al.
Hematology (Amsterdam, Netherlands)|January 2, 2026
Application of single nucleotide polymorphism array (SNP array) derived median copy number state for monitoring the clonal burden of the chromosomal aberrations in myelodysplastic neoplasmsLili Song, Zhenxiu Guo, Kun Chi
Hematology (Amsterdam, Netherlands)|October 30, 2020
Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative studySeied Asadollah Mousavi, Soroush Rad, Tahereh Rostami, et al.
Hematology (Amsterdam, Netherlands)|December 9, 2020
Normal activated partial thromboplastin time in Chinese patients with mild hemophilia BXiong Wang, Ning Tang, Na Shen, et al.
Hematology (Amsterdam, Netherlands)|December 10, 2020
Tacrolimus is effective in relapsed/refractory autoimmune cytopenias: results of a single-center retrospective studyYali Du, Chen Yang, Miao Chen, et al.
Hematology (Amsterdam, Netherlands)|July 27, 2021
Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myelomaWenmin Han, Yuanyuan Jin, Min Xu, et al.
Hematology (Amsterdam, Netherlands)|May 27, 2022
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantationHaruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, et al.
Hematology (Amsterdam, Netherlands)|May 27, 2022
AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcomeNada Assaf, Christine Lefebvre, Victoria Raggueneau, et al.
Pageof 265